Skip to main content

Table 2 Estimated malaria cases averted

From: Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage

Country

Total cases averted in thousands

Children using an ITN

Children not using an ITN

Cases averted in thousands (uncertainty range)

Percentage of total averted across all countries

Cases averted in thousands (uncertainty range)

Percentage of total averted across all countries

Angola

162 (143–180)

54 (47–60)

0

109 (96–121)

1

Benin

282 (248–313)

220 (193–244)

1

63 (55–69)

0

Burkina Faso

1326 (1167–1473)

729 (641–809)

4

597 (525–663)

3

Burundi

583 (513–647)

237 (208–263)

1

346 (305–385)

2

Cameroon

1359 (1195–1508)

219 (193–243)

1

1140 (1002–1265)

6

Democratic Republic of Congo

2307 (2029–2562)

1420 (1249–1576)

7

888 (781–985)

4

Côte d’Ivoire

834 (733–926)

433 (381–481)

2

400 (352–445)

2

Ghana

836 (736–929)

465 (409–516)

2

371 (327–412)

2

Guinea

396 (348–439)

160 (140–177)

1

236 (208–262)

1

Kenya

536 (471–595)

399 (351–443)

2

137 (120–152)

1

Liberia

222 (195–246)

94 (82–104)

0

128 (113–142)

1

Malawi

930 (818–1033)

416 (366–462)

2

514 (452–571)

3

Mali

575 (506–638)

465 (409–516)

2

110 (97–123)

1

Mozambique

1251 (1100–1389)

692 (608–768)

3

559 (492–621)

3

Nigeria

5684 (4999–6311)

2887 (2539–3205)

14

2797 (2460–3106)

14

Sierra Leone

351 (309–390)

204 (180–227)

1

147 (129–163)

1

Tanzania

522 (459–580)

338 (297–376)

2

184 (162–204)

1

Togo

578 (508–641)

264 (232–293)

1

314 (276–348)

2

Uganda

1317 (1158–1462)

889 (782–987)

4

428 (377–476)

2

Zambia

491 (432–545)

245 (215–272)

1

246 (217–273)

1

Total

20,542 (18,066–22,807)

10,827 (9522–12,021)

53

9715 (8544–10,786)

47

  1. The numbers of cases, and percentage relative to the total across all countries, that could be averted annually in 12–59-month-old children if universal coverage of the RTS,S/AS01 vaccine was achieved, for those who received the DTP3 vaccine in each country, assuming that all children who received the DTP3 vaccine also received all four doses of the RTS,S malaria vaccine. These estimates are calculated for individual admin-1 units and aggregated at the country level. Uncertainty ranges in parentheses represent the calculated impact based on the 95% vaccine efficacy confidence interval reported in the clinical trial [18]